ENDO 2025 Abstract·23 OctSUN-691 Permeate: A Novel Platform for Enhanced Incretin Peptide BioavailabilityExperiments in animalsInterventionsPaper
ENDO 2025 Abstract·23 OctSUN-664 SYNT-101: First-in-Human Evaluation of a Novel Pharmacologic Therapeutic to Replicate Gastric Bypass for Management of ObesityTrial in peopleInterventionsPaper
ENDO 2025 Abstract·23 OctSUN-663 Preclinical Evaluation of SYNT-101: Effects on Glycemic Control, Weight Loss, and Body Composition in DIO RodentsExperiments in animalsInterventionsPaper